Antidepressants for depression in pregnancy: new systematic review says the jury’s still out

Nikki Newhouse summarises a recent US health technology assessment of antidepressants for depression in pregnancy and the postpartum period, which concludes that the evidence remains inconclusive about the benefits and harms of antidepressants for depression in pregnancy.

[read the full story...]

Cyberbullying and mental health in young people

shutterstock_202558144

Elly O’Brien summarises a recent US survey of adolescents, which investigates the relationship between cyberbullying, mental health and substance use problems, and the moderating role of family dinners.

[read the full story...]

Are autism and ADHD associated with antidepressants or maternal depression? The debate continues…

 

Amy Green summarises a retrospective observational study that finds prenatal antidepressant exposure is associated with risk for ADHD, but not autistic spectrum disorders. She considers this complex topic and works out what it all means for pregnant women with depression.

[read the full story...]

CBT in primary care is cost-effective for treatment-resistant depression

shutterstock_181677467

Elf economist Chris Sampson reports on the economic evaluation of the CoBalT RCT, which finds that CBT is cost-effective for treatment resistant depression in primary care.

[read the full story...]

Exercise for the prevention and treatment of antenatal depression

shutterstock_59173807

Meg Fluharty summarises a recent systematic review looking at exercise for antenatal depression. The review finds preliminary evidence to suggest that exercise may be effective in reducing depression during pregnancy, but the quality of included trials is low to moderate.

[read the full story...]

Ketamine for depression: new review highlights the need for an RCT

shutterstock_178955465

Helge Hasselmann reviews a new systematic review of ketamine for depression, which highlights the need for an RCT to provide reliable data on the safety, tolerability and best route of administration.

[read the full story...]

Placebo for depression: are some sugar pills better than others?

shutterstock_213336247

Joe Judge revels in a new network meta-analysis looking at placebo for depression published in BMC Medicine, which has been supplemented by a series of commentaries and blogs. Thought-provoking stuff!

[read the full story...]

Interpersonal therapy and imipramine may be effective at reducing suicidal ideation in depression, but more research needed

shutterstock_162657821

Susie Johnson considers how effective conventional depression treatments are at reducing suicidal ideation in depression. The new study she summarises concludes that interpersonal therapy and antidepressants can also reduce suicidal ideation.

[read the full story...]

Face-to-face psychotherapy for chronic pain in children and adolescents: Cochrane review calls for better primary research

Caption

Lisa Burscheidt summarises a recent Cochrane review of psychotherapy for chronic pain in children and adolescents, which concludes that psychological therapies should be considered as a treatment, but better primary studies are needed to help steer pain management decisions.

[read the full story...]

Mental disorders after critical illness: depression, PTSD and functional disability in survivors of intensive care

shutterstock_155305655-150x150

The BRAIN-ICU prospective cohort study published in the Lancet Respiratory Medicine looks at mental health outcomes and functional disabilities in a general ICU population. It explores the hypothesis that depressive symptoms after discharge are more often somatic (i.e. bodily complaints) than cognitive-affective (i.e. thought-related and mood-related complaints).

[read the full story...]